Pharvaris (PHVS) Times Interest Earned (2021 - 2026)

Pharvaris' (PHVS) quarterly Times Interest Earned came in at $0.0 in Q3 2024, down 99.97% on a QoQ basis from $1.0 in Q4 2023.

Analysis

Pharvaris (PHVS) Times Interest Earned (2021 - 2026) Analysis & Trends

Pharvaris (PHVS) has 5 years of Times Interest Earned data on file, last reported at $0.0 in Q3 2024.

Quarterly Times Interest Earned changed N/A year-over-year to $0.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $241.5 (down 100.0% YoY) and the FY2023 annual result came in at $0.0, up 100.0% from the prior year.
Times Interest Earned eased to $0.0 in Q3 2024, from $1.0 in the prior quarter.
In the past five years, Times Interest Earned ranged from a high of $1149.7 in Q4 2022 to a low of -$1453.6 in Q4 2021.
A 5-year average of -$65.76 and a median of -$25.8 in 2021 frame the typical range for Times Interest Earned.
The widest YoY moves for Times Interest Earned: up 184.09% in 2022, down 407.76% in 2022.
Tracing PHVS's Times Interest Earned over 5 years: stood at -$135.02 in 2020, then sank by 976.57% to -$1453.6 in 2021, then surged by 179.09% to $1149.7 in 2022, then sank by 99.91% to $1.0 in 2023, then sank by 99.97% to $0.0 in 2024.
The last three Times Interest Earned figures came in at $0.0 (Q3 2024), $1.0 (Q4 2023), and $1149.7 (Q4 2022), per Business Quant data.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Times Interest Earned (Qtr)
1	Vertex Pharmaceuticals	138.47 Bn	130.62 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.18 Bn	77.19 Bn	3.93 Bn	117.59
3	Argenx Se	63.38 Bn	58.19 Bn	1.37 Bn	-493.00
4	Moderna	58.09 Bn	52.95 Bn	52.00 Mn	-
5	Revolution Medicines	44.33 Bn	44.33 Bn	-	-21.24
6	BeOne Medicines	40.02 Bn	34.92 Bn	1.53 Bn	8.18
7	Alnylam Pharmaceuticals	35.57 Bn	32.27 Bn	992.69 Mn	2.82
8	Royalty Pharma	28.45 Bn	27.61 Bn	-	1.42
9	Insmed	27.48 Bn	26.32 Bn	358.27 Mn	-0.08
10	Pharvaris	2.10 Bn	1.73 Bn	85,072.10	-13.32

Historic Data

Download Data